Rowland & CO Investment Counsel Mimedx Group, Inc. Transaction History

Rowland & CO Investment Counsel

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$5.52 - $15.83 $55,199 - $158,300	-10,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$8.48 - $11.28 $84,800 - $112,800	10,000 New	10,000 $103,000
Q4 2018 Feb 12, 2019	SELL	$1.15 - $6.45 $212,661 - $1.19 Million	-184,923 Closed	0 $0
Q4 2017 Jan 11, 2018	SELL	$10.87 - $13.9 $316,066 - $404,170	-29,077 Reduced 13.59%	184,923 $0
Q3 2017 Oct 11, 2017	BUY	$11.86 - $17.34 $106,740 - $156,060	9,000 Added 4.39%	214,000 $0
Q3 2017 Oct 11, 2017	BUY	$11.86 - $17.34 $2.43 Million - $3.55 Million	205,000	205,000 $0

211

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.04B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Rowland & CO Investment Counsel with notifications on news.